Surgical treatment of oligometastatic non-small cell lung cancer

Lung Cancer

Volumn 69, Issue 3, 2010, Pages 251-258

  Pfannschmidt, Joachim ^a   Dienemann, Hendrik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Non small cell lung cancer; Oligometastatic disease; Surgery

Indexed keywords

FLUORODEOXYGLUCOSE;

ADRENAL METASTASIS; BRAIN METASTASIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE;

EID: 77955093572     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.05.003     Document Type: Review

References (85)

1. Ramalingam S., Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 2008, 13(Suppl 1):5-13.
2. Quint L.E., Tummala S., Brisson L.J., Francis I.R., Krupnick A.S., Kazerooni E.A., et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996, 62(1):246-250.
3. Luketich J.D., Martini N., Ginsberg R.J., Rigberg D., Burt M.E. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg 1995, 60(6):1609-1611.
4. Albain K.S., Crowley J.J., LeBlanc M., Livingston R.B. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991, 9(9):1618-1626.
5. Hellman S., Weichselbaum R.R. Oligometastases. J Clin Oncol 1995, 13(1):8-10.
6. Postmus P.E., Brambilla E., Chansky K., Crowley J., Goldstraw P., Patz E.F., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007, 2(8):686-693.
7. Pujol J.L., Chakra M. Staging metastasis profile of non-small cell lung cancer: a new paradigm?. J Thorac Oncol 2007, 2(8):679-681.
8. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989, 8(2):98-101.
9. Fidler I.J. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am 2001, 10(2):257-269. vii-viiii.
10. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3(6):453-458.
11. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2(8):563-572.
12. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009, 9(4):274-284.
13. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., et al. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436(7050):518-524.
14. Kang Y. New tricks against an old foe: molecular dissection of metastasis tissue tropism in breast cancer. Breast Dis 2006, 26:129-138.
15. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536.
16. Grinberg-Rashi H., Ofek E., Perelman M., Skarda J., Yaron P., Hajduch M., et al. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res 2009, 15(5):1755-1761.
17. Weinberg R.A. The many faces of tumor dormancy. Apmis 2008, 116(7-8):548-551.
18. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997, 113(1):37-49.
19. Hellman S., Weichselbaum R.R. Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol 2005, 2(2):60-61.
20. Santoro M., Petitto P., Pingitore D. Oligometastases: a new reality in the therapy of the cancer. EJC Suppl 2008, 6(14):139.
21. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2(7):593-602.
22. Zell J.A., Ou S.H., Ziogas A., Anton-Culver H. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules. Cancer 2008, 112(1):136-143.
23. Martini N., Melamed M.R. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975, 70(4):606-612.
24. Girard N., Ostrovnaya I., Lau C., Park B., Ladanyi M., Finley D., et al. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers. Clin Cancer Res 2009, 15(16):5184-5190.
25. Weiss M.M., Kuipers E.J., Meuwissen S.G., van Diest P.J., Meijer G.A. Comparative genomic hybridisation as a supportive tool in diagnostic pathology. J Clin Pathol 2003, 56(7):522-527.
26. Girard N., Deshpande C., Lau C., Finley D., Rusch V., Pao W., et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009, 33(12):1752-1764.
27. Pfannschmidt J., Dienemann H., Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007, 84(1):324-338.
28. Voltolini L., Rapicetta C., Luzzi L., Ghiribelli C., Paladini P., Granato F., et al. Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup. Eur J Cardiothorac Surg 2009.
29. De Leyn P., Moons J., Vansteenkiste J., Verbeken E., Van Raemdonck D., Nafteux P., et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg 2008, 34(6):1215-1222.
30. Richards P., Mc K.W. Intracranial metastases. Br Med J 1963, 1(5322):15-18.
31. Deutsch M., Parsons J.A., Mercado R. Radiotherapy for intracranial metastases. Cancer 1974, 34(5):1607-1611.
32. Deeley T.J., Edwards J.M. Radiotherapy in the management of cerebral secondaries from bronchial carcinoma. Lancet 1968, 1(7554):1209-1213.
33. Mussi A., Pistolesi M., Lucchi M., Janni A., Chella A., Parenti G., et al. Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. J Thorac Cardiovasc Surg 1996, 112(1):146-153.
34. Sanghavi S.N., Miranpuri S.S., Chappell R., Buatti J.M., Sneed P.K., Suh J.H., et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001, 51(2):426-434.
35. Kondziolka D., Patel A., Lunsford L.D., Kassam A., Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45(2):427-434.
36. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363(9422):1665-1672.
37. Hoffman R., Sneed P.K., McDermott M.W., Chang S., Lamborn K.R., Park E., et al. Radiosurgery for brain metastases from primary lung carcinoma. Cancer J 2001, 7(2):121-131.
38. Bindal A.K., Bindal R.K., Hess K.R., Shiu A., Hassenbusch S.J., Shi W.M., et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996, 84(5):748-754.
39. O'Neill B.P., Iturria N.J., Link M.J., Pollock B.E., Ballman K.V., O'Fallon J.R. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003, 55(5):1169-1176.
40. Modha A., Shepard S.R., Gutin P.H. Surgery of brain metastases-is there still a place for it?. J Neurooncol 2005, 75(1):21-29.
41. Al-Shamy G., Sawaya R. Management of brain metastases: the indispensable role of surgery. J Neurooncol 2009, 92(3):275-282.
42. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322(8):494-500.
43. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., Padberg G.W., Voormolen J.H., Hoekstra F.H., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993, 33(6):583-590.
44. Mintz A.H., Kestle J., Rathbone M.P., Gaspar L., Hugenholtz H., Fisher B., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78(7):1470-1476.
45. Paek S.H., Audu P.B., Sperling M.R., Cho J., Andrews D.W. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005, 56(5):1021-1034. [discussion 1021-34].
46. Stark A.M., Tscheslog H., Buhl R., Held-Feindt J., Mehdorn H.M. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005, 28(2):115-119.
47. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280(17):1485-1489.
48. Regine W.F., Huhn J.L., Patchell R.A., St Clair W.H., Strottmann J., Meigooni A., et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 2002, 52(2):333-338.
49. Karlovits B.J., Quigley M.R., Karlovits S.M., Miller L., Johnson M., Gayou O., et al. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 2009, 27(6):E7.
50. Soltys S.G., Adler J.R., Lipani J.D., Jackson P.S., Choi C.Y., Puataweepong P., et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008, 70(1):187-193.
51. Do L., Pezner R., Radany E., Liu A., Staud C., Badie B. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases. Int J Radiat Oncol Biol Phys 2009, 73(2):486-491.
52. Mintz A., Perry J., Spithoff K., Chambers A., Laperriere N. Management of single brain metastasis: a practice guideline. Curr Oncol 2007, 14(4):131-143.
53. Saitoh Y., Fujisawa T., Shiba M., Yoshida S., Sekine Y., Baba M., et al. Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 1999, 24(2):99-106.
54. Wronski M., Arbit E., Burt M., Galicich J.H. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 1995, 83(4):605-616.
55. Iwasaki A., Shirakusa T., Yoshinaga Y., Enatsu S., Yamamoto M. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Eur J Cardiothorac Surg 2004, 26(3):488-493.
56. Furak J., Trojan I., Szoke T., Agocs L., Csekeo A., Kas J., et al. Lung cancer and its operable brain metastasis: survival rate and staging problems. Ann Thorac Surg 2005, 79(1):241-247. [discussion 241-7].
57. Macchiarini P., Buonaguidi R., Hardin M., Mussi A., Angeletti C.A. Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis. Cancer 1991, 68(2):300-304.
58. Bonnette P., Puyo P., Gabriel C., Giudicelli R., Regnard J.F., Riquet M., et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001, 119(5):1469-1475.
59. Billing P.S., Miller D.L., Allen M.S., Deschamps C., Trastek V.F., Pairolero P.C. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 2001, 122(3):548-553.
60. Abrams H.L.S.R., Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950, 3:74-85.
61. Burt M., Heelan R.T., Coit D., McCormack P.M., Bains M.S., Martini N., et al. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. J Thorac Cardiovasc Surg 1994, 107(2):588-589. [discussion 584-8].
62. Porte H.L., Roumilhac D., Graziana J.P., Eraldi L., Cordonier C., Puech P., et al. Adrenalectomy for a solitary adrenal metastasis from lung cancer. Ann Thorac Surg 1998, 65(2):331-335.
63. Ettinghausen S.E., Burt M.E. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. J Clin Oncol 1991, 9(8):1462-1466.
64. McNicholas M.M., Lee M.J., Mayo-Smith W.W., Hahn P.F., Boland G.W., Mueller P.R. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR Am J Roentgenol 1995, 165(6):1453-1459.
65. Kim H.K., Choi Y.S., Kim K., Kim J., Shim Y.M. Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. Lung Cancer 2007, 58(3):342-347.
66. Feliciotti F., Paganini A.M., Guerrieri M., Baldarelli M., De Sanctis A., Campagnacci R., et al. Laparoscopic anterior adrenalectomy for the treatment of adrenal metastases. Surg Laparosc Endosc Percutan Tech 2003, 13(5):328-333.
67. Beitler A.L., Urschel J.D., Velagapudi S.R., Takita H. Surgical management of adrenal metastases from lung cancer. J Surg Oncol 1998, 69(1):54-57.
68. Thompson G.B., Grant C.S., van Heerden J.A., Schlinkert R.T., Young W.F., Farley D.R., et al. Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997, 122(6):1132-1136.
69. Strong V.E., D'Angelica M., Tang L., Prete F., Gonen M., Coit D., et al. Laparoscopic adrenalectomy for isolated adrenal metastasis. Ann Surg Oncol 2007, 14(12):3392-3400.
70. Downey R.J., Ng K.K., Kris M.G., Bains M.S., Miller V.A., Heelan R., et al. A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. Lung Cancer 2002, 38(2):193-197.
71. Tanvetyanon T., Robinson L.A., Schell M.J., Bains M.S., Miller V.A., Heelan R., et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol 2008, 26(7):1142-1147.
72. Porte H., Siat J., Guibert B., Lepimpec-Barthes F., Jancovici R., Bernard A., et al. Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 2001, 71(3):981-985.
73. Abdel-Raheem M.M., Potti A., Becker W.K., Saberi A., Scilley B.S., Mehdi S.A. Late adrenal metastasis in operable non-small-cell lung carcinoma. Am J Clin Oncol 2002, 25(1):81-83.
74. Luketich J.D., Burt M.E. Does resection of adrenal metastases from non-small cell lung cancer improve survival?. Ann Thorac Surg 1996, 62(6):1614-1616.
75. Ayabe H., Tsuji H., Hara S., Tagawa Y., Kawahara K., Tomita M. Surgical management of adrenal metastasis from bronchogenic carcinoma. J Surg Oncol 1995, 58(3):149-154.
76. Ambrogi V., Tonini G., Mineo T.C. Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer. Ann Surg Oncol 2001, 8(8):663-666.
77. Hishida T., Nagai K., Yoshida J., Nishimura M., Ishii G., Iwasaki M., et al. Is surgical resection indicated for a solitary non-small cell lung cancer recurrence?. J Thorac Cardiovasc Surg 2006, 131(4):838-842.
78. Lang H., Nussbaum K.T., Weimann A., Raab R. Liver resection for non-colorectal, non-neuroendocrine hepatic metastases. Chirurg 1999, 70(4):439-446.
79. Pericleous S., Mukherjee S., Hutchins R.R. Lung adenocarcinoma presenting as obstructive jaundice: a case report and review of literature. World J Surg Oncol 2008, 6:120.
80. McKeown P.P., Conant P., Auerbach L.E. Squamous cell carcinoma of the lung: an unusual metastasis to pectoralis muscle. Ann Thorac Surg 1996, 61(5):1525-1526.
81. Santini M., Vicidomini G., Di Marino M.P., Baldi A. Solitary muscle metastasis from lung carcinoma. J Cardiovasc Surg (Torino) 2001, 42(5):701-702.
82. Hellwig D., Ukena D., Paulsen F., Bamberg M., Kirsch C.M. Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000. Pneumologie 2001, 55(8):367-377.
83. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003, 348(25):2500-2507.
84. Lardinois D., Weder W., Roudas M., von Schulthess G.K., Tutic M., Moch H., et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005, 23(28):6846-6853.
85. Blake M.A., Slattery J.M., Kalra M.K., Halpern E.F., Fischman A.J., Mueller P.R., et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 2006, 238(3):970-977.